Company profile: ScreenPoint Medical
1.1 - Company Overview
Company description
- Provider of deep learning and image analysis technology for automated reading of mammograms and digital breast tomosynthesis. Offers Transpara software that assists radiologists by categorizing and prioritizing exams, differentiating those with a high probability of suspicious findings, and providing workflow enhancements, combining machine learning advances with very large, well-curated digital image databases.
Products and services
- Automated Mammogram Reading Technology: Architects physics-informed Deep Learning image analysis for automated reading of mammograms, exploiting very large well-curated digital image databases and mammogram image physics
- Digital Breast Tomosynthesis Image Analysis: Develops Deep Learning-based automated reading for digital breast tomosynthesis, combining latest machine learning methods with very large well-curated digital image databases and mammogram image physics
- Transpara: Produces software-based assistance that categorizes and prioritizes mammograms, differentiates exams with high probability of suspicious findings, and delivers workflow enhancements for radiologists during reading.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ScreenPoint Medical
Suros Surgical
HQ: United States
Website
- Description: Provider of award-winning, Indiana-based medical devices enabling minimally invasive tissue excision and biopsy across multiple surgical specialties, built on patented surgical platform technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Suros Surgical company profile →
LungLife AI
HQ: United States
Website
- Description: Provider of molecular diagnostics for early cancer detection and treatment, offering the LungLB® Test, a blood-based diagnostic that provides additional information to clinicians evaluating indeterminate lung nodules, potentially reducing unnecessary invasive procedures and delays in treatment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LungLife AI company profile →
Foundation Medicine
HQ: United States
Website
- Description: Provider of molecular information and clinical diagnostic tests for personalized cancer care, including FoundationOne CDx tissue-based comprehensive genomic profiling, FoundationOne Liquid CDx blood-based ctDNA profiling, FoundationOne Heme for hematologic malignancies, FoundationOne RNA fusion detection in solid tumors, the FoundationCore cancer genomic database, and Molecular Tumor Boards.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Foundation Medicine company profile →
Fate Therapeutics
HQ: United States
Website
- Description: Provider of iPSC-derived cellular therapeutics and platform technologies, offering a proprietary clonal master iPSC platform for off-the-shelf therapies; CAR T and CAR NK candidates including FT819 (CD19 for systemic lupus erythematosus and other autoimmune diseases), FT522 (CAR NK with alloimmune defense receptor for B-cell lymphoma and autoimmune diseases), FT825 (HER2 solid tumors), plus NK and T-cell programs for cancer.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fate Therapeutics company profile →
Apceth Biopharma
HQ: Germany
Website
- Description: Provider of GMP-compliant contract development and manufacturing services for complex cell and gene therapy products (ATMPs). Services include GMP manufacturing for clinical and commercial therapies, process development and optimization, analytical testing and quality control, cell therapy consulting, QP batch certification and EU import, supported by GMP facilities across North America, Europe, and Asia.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Apceth Biopharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ScreenPoint Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ScreenPoint Medical
2.2 - Growth funds investing in similar companies to ScreenPoint Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ScreenPoint Medical
4.2 - Public trading comparable groups for ScreenPoint Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →